🇺🇸 FDA
Pipeline program

Telavancin

I6424-202a

Phase 2 small_molecule completed

Quick answer

Telavancin for Infections, Gram-Positive Bacterial is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Infections, Gram-Positive Bacterial
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials